Norma Velazquez-Guadarrama

Prof. Dr. Norma Velazquez-Guadarrama

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2021 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
EAEric Avila-Calderon
Eric Avila-Calderon
MRMaría del Socorro Ruiz-Palma
María del Socorro Ruiz-Palma
MAMa. Guadalupe Aguilera-Arreola
Ma. Guadalupe Aguilera-Arreola
NVNorma Velazquez-Guadarrama
Norma Velazquez-Guadarrama
EREnrico A. Ruiz
Enrico A. Ruiz
ACARACELI Contreras-Rodríguez
ARACELI Contreras-Rodríguez
Outer membrane vesicles (OMVs) from Gram-negative bacteria were first described more than 50 years ago. However, the molecular mechanisms involved in biogenesis began to be studied only in the last few decades. Presently, the biogenesis and molecular mechanisms for their release are not completely known. This review covers the most recent information on cellular components involved in OMV biogenesis, such as lipoproteins and outer membrane proteins, lipopolysaccharide, phospholipids, quorum-sensing molecules, and flagella.

17 April 2013 in Pathogens and Disease
Verified
Journal Article
Closed access
PDF file
RGRodolfo García-Contreras
Rodolfo García-Contreras
MMMariano Martínez-Vázquez
Mariano Martínez-Vázquez
NVNorma Velazquez-Guadarrama
Norma Velazquez-Guadarrama
APAlejandra Guadalupe Villegas Pañeda
Alejandra Guadalupe Villegas Pañeda
THTakahiro Hashimoto
Takahiro Hashimoto
Thomas WoodThomas Wood
Thomas Wood

9 November 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
Maria Melissa Gutierrez-PachecoMaria Melissa Gutierrez-Pacheco
Maria Melissa Gutierrez-Pacheco
HTHeriberto Torres-Moreno
Heriberto Torres-Moreno
María L. Flores-LópezMaría L. Flores-López
María L. Flores-López
NVNorma Velazquez-Guadarrama
Norma Velazquez-Guadarrama
J. FERNANDO AYALA-ZAVALAJ. FERNANDO AYALA-ZAVALA
J. FERNANDO AYALA-ZAVALA
Julio César López RomeroJulio César López Romero
Julio César López Romero
Citral is a monoterpene constituted by two isomers known as neral and geranial. It is present in different plant sources and recognized as safe (GRAS) by the Food and Drug Administration (FDA). In recent years, investigations have demonstrated that this compound exhibited several biological activities, such as antibacterial, antifungal, antibiofilm, antiparasitic, antiproliferative, anti-inflammatory, and antioxidant properties, by in vitro and in vivo assays. Additionally, when incorporated into different food matrices, citral can reduce the microbial load of pathogenic microorganisms and extend the shelf life. This compound has acceptable drug-likeness properties and does not present any violations of Lipinski’s rules, which could be used for drug development. The above shows that citral could be a compound of interest for developing food additives to extend the shelf life of animal and vegetable origin foods and develop pharmaceutical products.

8 May 2019 in Metallomics
Verified
Journal Article
Closed access
PDF file
EOEdgar Augusto Ortiz-Benítez
Edgar Augusto Ortiz-Benítez
NVNorma Velazquez-Guadarrama
Norma Velazquez-Guadarrama
NDNoe Duran-Figueroa
Noe Duran-Figueroa
HQHéctor Quezada
Héctor Quezada
JOJosé de Jesús Olivares-Trejo
José de Jesús Olivares-Trejo
Streptococcus pneumoniae is a causal agent of otitis media, pneumonia, meningitis and severe cases of septicemia. This human pathogen infects elderly people and children with a high mortality rate of approximately one million deaths per year worldwide. Antibiotic-resistance of S. pneumoniae strains is an increasingly serious health problem; therefore, new therapies capable of combating pneumococcal infections are indispensable. The application of gold nanoparticles has emerged as an option in the control of bacterial infections; however, the mechanism responsible for bacterial cell lysis remains unclear. Specifically, it has been observed that gold nanoparticles are capable of crossing different structures of the S. pneumoniae cells, reaching the cytosol where inclusion bodies of gold nanoparticles are noticed. In this work, a novel process for the separation of such inclusion bodies that allowed the analysis of the biomolecules such as carbohydrates, lipids and proteins associated with the gold nanoparticles was developed. Then, it was possible to separate and identify proteins associated with the gold nanoparticles, which were suggested as possible candidates that facilitate the interaction and entry of gold nanoparticles into S. pneumoniae cells.

1 October 2013 in Archives of Medical Research
Verified
Journal Article
Closed access
ICIsrael Castillo-Juárez
Israel Castillo-Juárez
RGRodolfo García-Contreras
Rodolfo García-Contreras
NVNorma Velazquez-Guadarrama
Norma Velazquez-Guadarrama
MSMarcos Soto-Hernández
Marcos Soto-Hernández
MMMariano Martínez-Vázquez
Mariano Martínez-Vázquez

15 September 2018 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
ACAna Caren Cortés-Márquez
Ana Caren Cortés-Márquez
SMSandra Mendoza-Elizalde
Sandra Mendoza-Elizalde
FAFrancisco Arenas-Huertero
Francisco Arenas-Huertero
JTJimena Trillo-Tinoco
Jimena Trillo-Tinoco
PVPedro Valencia-Mayoral
Pedro Valencia-Mayoral
NVNorma Velazquez-Guadarrama
Norma Velazquez-Guadarrama
Helicobacter pylori is a major aetiologic agent associated with gastritis. H. pylori infections increase the expression of the Toll-like receptor (TLR), which in turn modulates the expression of microRNA (miRNA)-146a and miRNA-155. The objective of this study was to compare the expression of miRNA-146a and miRNA-155 in gastric lesions of paediatric and adult patients with different pathologies and in Mongolian gerbils (Meriones unguiculatus) infected with H. pylori 26,695. Quantification of miRNA expression was performed by quantitative real-time polymerase chain reaction (qRT-PCR) of paraffin-embedded gastric lesions of children with or without an infection (n = 25), adults with follicular gastritis and metaplasia (n = 32) and eight-week-old M. unguiculatus males (Hsd:MON) infected with H. pylori 26,695 for 0, 3, 6, 12 and 18 months (n = 25). The genes RNU48 and RNU6 were used as endogenous controls for data normalization. Statistical analyses were performed using Kruskal-Wallis, Mann-Whitney, ANOVA and Student’s t-test. The expression of miRNA-146a and miRNA-155 in infected children increased by 247.6- and 79.4-fold (on average), respectively, compared to that observed in the control group. However, these results were not significant (p = 0.12 and p = 0.07 respectively). In some children a gradual increase in expression was observed, while in others, expression was very high. Additionally, the expression levels of miRNA-146a and miRNA-155 increased by an average of 21.7- and 62-fold, respectively, in adult patients with follicular gastritis when compared to those of the controls. In M. unguiculatus infected with H. pylori 26,695, the expression of both miRNAs increased as the infection progressed. This is the first report to show differences in the expression of miRNA-146a and miRNA-155 in paediatric and adult patients with gastritis who were infected with H. pylori. In addition, in M. unguiculatus infected with H. pylori, miRNA expression was associated with the progression of infection and the ability of the bacteria to adapt to the host.